Singapore markets close in 28 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.3972-0.0208 (-1.47%)
At close: 02:49PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.75
52-week change 3-41.65%
S&P500 52-week change 3-8.47%
52-week high 33.5000
52-week low 30.5850
50-day moving average 31.4915
200-day moving average 31.5891

Share statistics

Avg vol (3-month) 317.27k
Avg vol (10-day) 310.32k
Shares outstanding 520M
Implied shares outstanding 6N/A
Float 817.78M
% held by insiders 111.50%
% held by institutions 10.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Dec 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)29 Sept 2022


Profit margin -11.45%
Operating margin (ttm)1.50%

Management effectiveness

Return on assets (ttm)0.62%
Return on equity (ttm)-51.62%

Income statement

Revenue (ttm)92.27M
Revenue per share (ttm)4.65
Quarterly revenue growth (yoy)54.70%
Gross profit (ttm)43.67M
Net income avi to common (ttm)-10.56M
Diluted EPS (ttm)0.1300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.65M
Total cash per share (mrq)0.48
Total debt (mrq)60.57M
Total debt/equity (mrq)357.40
Current ratio (mrq)0.88
Book value per share (mrq)0.85

Cash flow statement

Operating cash flow (ttm)-1.04M
Levered free cash flow (ttm)-7.88M